Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 8:01 PM ET

Date/Time Source News Release
12/14/2020 04:30 PM EST GlobeNewswire ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
12/10/2020 04:30 PM EST GlobeNewswire ERYTECH to Present at the JMP Securities Hematology Summit
12/07/2020 02:00 AM EST GlobeNewswire ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting
12/03/2020 04:30 PM EST GlobeNewswire ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
11/12/2020 04:30 PM EST GlobeNewswire ERYTECH to Present at Jefferies Virtual Healthcare Conference
11/05/2020 04:30 PM EST GlobeNewswire ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2020
11/05/2020 02:00 AM EST GlobeNewswire ERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Selected for Oral Presentation at the American Society of Hematology 2020 Annual Meeting
11/02/2020 03:19 AM EST GlobeNewswire ERYTECH Secures Euro10 Million in Non-Dilutive Financing, Guaranteed by the French Government
10/29/2020 05:30 PM EDT GlobeNewswire ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020
10/26/2020 05:30 PM EDT GlobeNewswire ERYTECH Appoints Stewart Craig as Chief Technical Officer
Page

Additional News

As of June 13, 2025 • 8:01 PM ET

Date/Time Source News Release
06/27/2023 10:04 AM EDT SeekingAlpha ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
05/11/2023 08:36 AM EDT SeekingAlpha WW, BBIG and MCB among pre-market losers
05/09/2023 09:56 AM EDT y%wire Micro Cap Bid Up In Early Trading
05/09/2023 02:53 AM EDT SeekingAlpha Erytech Pharma reports Q1 results
04/17/2023 04:21 PM EDT SeekingAlpha ERYTECH receives approval to transfer its listing to Nasdaq Capital Market
03/22/2023 05:23 PM EDT SeekingAlpha Erytech Pharma reports FY results
10/13/2022 04:28 PM EDT SeekingAlpha ERYTECH receives non-compliance letter from Nasdaq
10/05/2022 12:00 PM EDT Zacks Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's Why
09/13/2022 11:15 AM EDT SeekingAlpha ERYTECH Pharma S.A. (ERYP) Q2 2022 Earnings Call Transcript
09/12/2022 04:38 PM EDT SeekingAlpha Erytech Pharma reports 1H results
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.